In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter

Corine Bertolotto; Karine Bille; Jean-Paul Ortonne; Robert Ballotti

doi:10.1038/sj.onc.1201685

Journal articles

In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter

Corine Bertolotto ¹ Karine Bille ¹ Jean-Paul Ortonne ² Robert Ballotti ³

1 Biologie et pathologies des cellules mélanocytaires : de la pigmentation cutanée aux mélanomes

2 Department of Dermatology

3 C3M - Centre méditérannéen de médecine moléculaire

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Cellular Biology

Complete list of metadatas

https://www.hal.inserm.fr/inserm-02533079
Contributor : Bertolotto-Ballotti Bertolotto-Ballotti <>
Submitted on : Monday, April 6, 2020 - 11:20:52 AM
Last modification on : Monday, October 12, 2020 - 10:27:51 AM

In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter

Links full text

Identifiers

Collections

Citation

Export

Metrics

39

In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

39